The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase IIB pre-surgical trial of oral tamoxifen (TAM) versus transdermal 4-hydroxytamoxifen (4-OHT) in women with DCIS of the breast.
 
Kelly A. Benante
No Relationships to Disclose
 
Yanfei Xu
No Relationships to Disclose
 
Mary Beth Tull
No Relationships to Disclose
 
Adrian J. Segura
No Relationships to Disclose
 
Katrina M. Alber
No Relationships to Disclose
 
Kiril Kalinichenko
Stock and Other Ownership Interests - Juno Therapeutics
 
Lifang Hou
No Relationships to Disclose
 
Borko Jovanovic
No Relationships to Disclose
 
Marjorie Perloff
No Relationships to Disclose
 
Brandy M. Heckman-Stoddard
No Relationships to Disclose
 
Eileen P. Dimond
No Relationships to Disclose
 
Seema Ahsan Khan
Research Funding - Repros Therapeutics